Skip to main content
. 2022 Sep 14;13(4):408–414. doi: 10.1055/s-0042-1756307

Table 1. Characteristics of children with septic shock and respiratory failure who survived to hospital discharge.

Characteristics Oxygenation failure absent
( n  = 122)
Mild oxygenation failure ( n  = 61) Moderate oxygenation failure ( n  = 58) Severe oxygenation failure ( n  = 50)
Sex, n (%)
 Male 63 (52) 32 (52) 37 (64) 28 (56)
 Female 59 (48) 29 (48) 21 (36) 22 (44)
Age in years, median (IQR) 6.7 (2.5–13.3) 4.4 (1.4–11.5) 4.6 (1.2–11.8) 7.2 (1.6–12.4)
Race/Ethnicity
 American Indian/Alaskan Native 4 (3%) 2 (3%) 2 (3%) 0 (0%)
 Asian 7 (6%) 2 (3%) 3 (5%) 3 (6%)
 Black or African-American 29 (24%) 6 (10%) 10 (17%) 14 (28%)
 White 73 (60%) 48 (79%) 40 (69%) 32 (64%)
 Native Hawaiian or Other Pacific Islander 2 (2%) 0 (0%) 0 (0%) 1 (2%)
 Unknown/Not reported 10 (8%) 6 (9%) 4 (7%) 2 (4%)
Baseline HRQL measure, median (IQR)
 PedsQL ( n  = 180) 82.6 (68.8–94.0) 79.7 (63.0–90.7) 82.7 (72.8–92.3) 80.6 (68.8–97.2)
 FS II-R ( n  = 111) 67.6 (60.7–85.7) 64.3 (53.6–85.7) 64.3 (57.1–78.6) 75.0 (60.7–85.7)
Baseline FSS, median (IQR) 7 (6–12) 7 (6–11) 6 (6–8) 6 (7–13)
Arterial lactate (mmol/L), median (IQR)
 Day of PICU admission ( n  = 155) 3.2 (2–5.1) 1.6 (1.1–3.1) 2.3 (1.4–4.1) 3.1 (1.6–5.5)
 Highest value ( n  = 233) 3.2 (2–5.3) 2.2 (1.4–3.4) 2.6 (1.8–4.4) 3.1 (2.3–7.6)
Vasoactive-inotropic score, median (IQR)
 Day of PICU admission ( n  = 283) 5 (0–12) 2 (0–12) 2.5 (0–10) 4 (0–15)
 Highest value 10 (5–20) 10 (5–18) 10 (5–20) 15 (8–28)
Medical history, n (%)
 Immunocompromised 22 (18) 4 (7) 6 (10) 9 (18)
 Congenital immunodeficiency 3 (6) 0 (0) 0 (0) 1 (4)
 Bone marrow/SCT 1 (2) 0 (0) 0 (0) 0 (0)
 Malignancy 3 (6) 0 (0) 2 (8) 4 (17)
 Rheumatologic disease 2 (4) 0 (0) 0 (0) 1 (4)
 Sickle cell disease 2 (4) 0 (0) 0 (0) 0 (0)
Medical complexity algorithm category
 No chronic comorbid conditions 59 (48%) 27 (44%) 37 (63%) 22 (44%)
 Chronic comorbid conditions (noncomplex) 4 (3%) 5 (8%) 4 (7%) 4 (8%)
 Chronic comorbid conditions (complex) 59 (48%) 28 (46%) 17 (29%) 24 (48%)
Baseline tracheostomy, n (%) 12 (10) 3 (3) 3 (5) 5 (10)
Adjunct respiratory support
 Neuromuscular blockade 88 (72%) 51 (84%) 48 (83%) 45 (90%)
 Days of neuromuscular blockade 1 (0–3) 2 (1–3) 3 (1–6) 5 (2–7)
 HFV 6 (5%) 2 (3%) 3 (5%) 11 (22%)
 ECLS 2 (2%) 2 (3%) 3 (5%) 7 (14%)
Mechanical ventilation days, median (IQR) 6 (4–10) 7 (5–12) 9.5 (6–15) 16 (10–27)
PICU LOS (d), median (IQR) 8 (5–12) 8 (6–15) 10 (8–14) 17.5 (11–28)
Hospital LOS (d), median (IQR) 15 (8–24) 15 (10–23) 16.5 (12–25) 28 (16–44)

Abbreviations: ECLS, extracorporeal life support or ventricular assist device; FS II-R, Functional Status II-Revised; FSS, Functional Status Scale; HFV, high frequency ventilation; HRQL, health-related quality of life; IQR, interquartile range; LOS, length of stay; PedsQL, Pediatric Quality of Life Inventory 4.0; PICU, pediatric intensive care unit.